C
Convalescent Plasma
Drug / MedicationMentioned in 1 video
Approved under Emergency Use Authorization by the FDA for COVID-19, despite lacking control in initial studies, highlighting the need for rapid deployment in pandemics.
Approved under Emergency Use Authorization by the FDA for COVID-19, despite lacking control in initial studies, highlighting the need for rapid deployment in pandemics.